HYBRID EVENT: Join us in person in Barcelona, Spain or attend virtually from anywhere.

4th Edition of International Heart Congress

June 22-24,2026 | Hybrid Event

June 22 -24, 2026 | Barcelona, Spain

Heart Congress 2026

Ahdy Wadie Helmy, Speaker at Heart Conferences
Keynote Presentation (In-Person)
Ahdy Wadie Helmy, Indiana University School of Medicine, United States

With Cardiovascular disease still the primary killer of adults globally, tackling lipid disorders has proven extremely useful from the statins experience since the early nineties. However, goals are not met regarding the lipid parameters for the vast majority of the world adult p [....] » Read More

Narendra Kumar, Speaker at Cardiology Conferences
Keynote Presentation (In-Person)
Narendra Kumar, HeartbeatsZ Academy, United Kingdom

In 2015, we celebrated PCSK9 inhibitors. In 2026, we're potentially approving FOUR revolutionary drug classes simultaneously. But will they succeed where others failed?" First, we examine Factor XI/XIa inhibition as a strategy to uncouple thrombosis from haemostasis, [....] » Read More

Sergey Suchkov, Speaker at Cardiovascular Conference
Keynote Presentation (In-Person)
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation

A new systems approach to diseased states and wellness result in a new branch in the healthcare services, namely, Personalized and Precision Medicine (PPM). The pace of inno-vation in Personalized & Precision Cardiology (PPC) is thus becoming fast including: The success [....] » Read More

Yangxin Li, Speaker at Cardiovascular Conference
Keynote Presentation (In-Person)
Yangxin Li, Soochow University, China

Cardiac aging is closely linked to cardiomyocyte (CM) senescence. Ribosome biogenesis plays acritical role in triggering CM cell cycle reentry; however, the specific activators and upstreamregulatorsofthis process remain unclear. Circular RNAs (circRNAs) have emerged as key regul [....] » Read More

Uwe Peter Tigor, Speaker at Cardiovascular Conference
Oral Presentation (In-Person)
Uwe Peter Tigor, Auxilius Pharma, United States

Background: Availability and use recommendations of anti-anginals in chronic-stable angina pectoris (CSAP) has changed little since the last anti-anginal was FDA approved in 2006. Recent large outcomes studies have changed consensus on management of CSAP. Guidelines again focus o [....] » Read More

Faizan Butt, Speaker at Cardiovascular Conference
Oral Presentation (In-Person)
Faizan Butt, Rutgers Jersey City Medical Center, United States

Introduction: Cocaine-induced cardiotoxicity is a well-recognized phenomenon associated with a broad spectrum of cardiovascular complications, including arrhythmias. We present a case of a 26-year-old male with a history of mitral valve prolapse (MVP) who developed accelerat [....] » Read More

Kayleigh Jarrett, Speaker at Heart Conferences
Oral Presentation (In-Person)
Kayleigh Jarrett, Robert Gordon University, United Kingdom

Background: Angina with No Obstructive Coronary Artery disease (ANOCA) is an umbrella term encompassing multiple underlying pathologies. Unlike traditional coronary artery disease (CAD), it is a complex condition, stemming from multifactorial structural and functional abnormaliti [....] » Read More

Hector Velasco Perez, Speaker at Cardiovascular Diseases Events
Oral Presentation (In-Person)
Hector Velasco Perez, KU Leuven, Belgium

In the last 30 years, people have devoted great efforts to generate models that reproduce the electrophysiological complexity of patient hearts. These models are referred to as digital twins and require a large number of parameters to be calibrated through experimental data and c [....] » Read More

Cristina Milagre Quadros Borges, Speaker at Heart Conferences
Oral Presentation (In-Person)
Cristina Milagre Quadros Borges, Heart Hospital - Hcor, Brazil

Cardiovascular diseases (CVD) correspond to the main cause of death worldwide in both genders. There was an increase in the prevalence of CVD in the last 30 years in young people aged 15-49 years, of both genders with proportional mortality was higher in women throughout the peri [....] » Read More

Sergey Suchkov, Speaker at Cardiovascular Conference
Oral Presentation (In-Person)
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation

Catalytic Abs (catAbs) are multivalent Immunoglobulins (Igs) with a capacity to hydrolyze the Antigenic (Ag) substrate. In this sense, proteolytic Abs (Ab-proteases) represent Abs to pro-vide proteolytic effects. Abs against Cardiac Myosin (CM) with proteolytic activity exhibitin [....] » Read More

Maria Teresa Carvallo Marin, Speaker at Cardiovascular Diseases Events
Oral Presentation (In-Person)
Maria Teresa Carvallo Marin, University of Chile, Chile

Introduction: After suffering a serious car- diovascular event (CV), cardiac rehabilitation is  a process in which the patient establishes a close  through a post-CV rehabilitation process. Stress was mentioned as the main CV risk factor (57%). Only 29% of  respond [....] » Read More

Yao Hua Song, Speaker at Heart Conferences
Oral Presentation (In-Person)
Yao Hua Song, Fuwai Yunnan Hospital, China

Skeletal muscle is a dynamic tissue endowed with exceptional plasticity and robust regenerative potential, which largely depends on satellite cells (SCs) residing between the muscle basement membrane and sarcolemma. The biogenesis, differentiation, and self-renewal of satellite c [....] » Read More

Yangxin Li, Speaker at Cardiovascular Conference
Oral Presentation (In-Person)
Yangxin Li, Soochow University, China

Heart failure remains a major global cause of morbidity and mortality. A significant challengeincardiac regeneration is the inability to generate new cardiomyocytes (CMs) through cell division, whichmaybe linked to ribosome biogenesis dysfunction associated with liquid–liqu [....] » Read More

Vivek Vaibhav, Speaker at Cardiovascular Diseases Events
Oral Presentation (In-Person)
Vivek Vaibhav, Saraswathi Institute of Medical Sciences, India

One significant cause of perioperative morbidity and mortality is intraoperative hemodynamic instability (IHI), which includes episodes of hypotension, hypertension, and arrhythmias. Current monitoring systems mainly alert clinicians when thresholds are violated, relying heavily [....] » Read More

Nidhish Niranjan Nisty, Speaker at Heart Conferences
Oral Presentation (In-Person)
Nidhish Niranjan Nisty, Nisty Heart Centre, India

Introduction: NT-proBNP (N-terminal pro-B-type Natriuretic Peptide) is a blood test used mainly to diagnose and monitor heart failure. It measures a hormone released by the heart when the heart muscle is stretched due to increased pressure or fluid overload. Methodology: The a [....] » Read More

Maria Antonette Bernal Gelindon, Speaker at Cardiology Conferences
Oral Presentation (In-Person)
Maria Antonette Bernal Gelindon, Philippine Heart Center, Philippines

Introduction: Application of strain echocardiography in Rheumatic Mitral Stenosis (MS) allows new insight in evaluation of cardiac function. The aim of this paper is to describe the significant change in right ventricular (RV) strain among patients with Rheumatic MS after Percuta [....] » Read More

Yu Jin Chung, Speaker at Cardiology Conferences
Oral Presentation (In-Person)
Yu Jin Chung, Konkuk University Hospital, Korea, Democratic People's Republic of

Although transcatheter aortic valve replacement (TAVR) has become a favorable option for severe aortic stenosis in older patients, post-procedural complications still exist. Commonly known complications include paravalvular leakage, vascular injury, stroke, and conduction abnorma [....] » Read More

Faizan Butt, Speaker at Cardiovascular Conference
Poster Presentation (In-Person)
Faizan Butt, Rutgers Jersey City Medical Center, United States

Background: Legionella pneumophila is a well-recognized cause of severe community-acquired pneumonia, particularly in patients presenting with hyponatremia and systemic inflammatory features. While pulmonary manifestations predominate, extrapulmonary involvement may occur. Cardia [....] » Read More

Mohammed Hashem, Speaker at Cardiovascular Diseases Events
Poster Presentation (In-Person)
Mohammed Hashem, Karolinska Institutet, Sweden

Background: The long-term impact of preoperative SARS-CoV-2 infection on patients undergoing surgical aortic valve replacement (SAVR) remains insufficiently defined, particularly in the pre-vaccination era. This study investigated whether previous COVID-19, determined by serology [....] » Read More

Federico Benetti, Speaker at Cardiovascular Conference
Keynote Presentation (Virtual)
Federico Benetti, Benetti Foundation, Argentina

Between 1970 and 1980 there were experiences and series of patients operated on Direct Coronary Surgery without the use of extracorporeal circulation. During the 80 and 90 the Technique was developed. The MIDCAB was the one that promoted the development of Coronary Surgery withou [....] » Read More

Mekhman N Mamedov, Speaker at Heart Conferences
Keynote Presentation (Virtual)
Mekhman N Mamedov, National Research Center for Preventive Medicine, Russian Federation

The aim of the study: was to analyze the characteristics of risk factors (RF) for cardiovascular disease (CVD) in individuals with type 1 diabetes mellitus. Materials and Methods: This cross-sectional multicenter study included 453 male and female patients with a verified [....] » Read More

Miroslav Radenkovic, Speaker at Cardiology Conferences
Keynote Presentation (Virtual)
Miroslav Radenkovic, University of Belgrade, Serbia

Pulmonary Arterial Hypertension (PAH) is still a devastating illness with substantial morbidity and death outcomes. Taking into account that the disease advances quickly for many patients, and is commonly associated with severe clinical symptoms, new treatment options are still r [....] » Read More

Shahe Tchillingirian, Speaker at Cardiovascular Conference
Oral Presentation (Virtual)
Shahe Tchillingirian, Icahn School of Medicine at Mount Sinai, United States

Torsades de Pointe (TdP) is a fatal arrhythmia that is a potential sequela of a prolonged QT interval. Most cases of TdP arise from medication-induced or congenital prolonged QT1. This case highlights an underrecognized association between panhypopituitarism and TdP, demonstrat [....] » Read More

Abdullah Muhammad Nasser, Speaker at Heart Conferences
Oral Presentation (Virtual)
Abdullah Muhammad Nasser, University of Toledo, United States

Background: Anomalous aortic origin of a coronary artery (AAOCA) is a rare congenital anomaly associated with myocardial ischemia and sudden cardiac death. The risk is particularly significant when the left main coronary artery (LMCA) arises from the right coronary sinus and [....] » Read More

Desislava Doycheva, Speaker at Cardiovascular Diseases Events
Oral Presentation (Virtual)
Desislava Doycheva, Loma Linda University, United States

Heart failure remains a major complication following myocardial infarction (MI), driven in part by sterile inflammation and adverse ventricular remodeling. While sodium-glucose cotransporter-2 (SGLT2) inhibitors have demonstrated robust cardiovascular benefits independent of glyc [....] » Read More

Sana Tariq, Speaker at Cardiology Conferences
Oral Presentation (Virtual)
Sana Tariq, Manchester University NHS Foundation Trust, United Kingdom

A 64-year-old woman with a history of diverticulosis and duodenal ulcer presented with classic signs and symptoms of ST-elevation myocardial infarction (STEMI), including chest pain typical of cardiac origin, ST elevations on ECG, and raised cardiac biomarkers. She was a former s [....] » Read More

Ieva Malinauskaite, Speaker at Cardiovascular Conference
Oral Presentation (Virtual)
Ieva Malinauskaite, Luzern Hospital, Switzerland

Background: Gender differences in cardiac structure may reflect body size and comorbidity patterns and have implications for diagnosis and risk stratification in older adults. The aim is to compare left ventricular wall thickness (LVWT) and left atrial (LA) size between older men [....] » Read More

Mindaugas Malinauskas, Speaker at Cardiovascular Conference
Oral Presentation (Virtual)
Mindaugas Malinauskas, Klaipeda City Multispecialty Clinic, Lithuania

Background: Gender differences in cardiac structure may reflect body size and comorbidity patterns and have implications for diagnosis and risk stratification in older adults. The aim is to compare left ventricular wall thickness (LVWT) and left atrial (LA) size between older men [....] » Read More

Agustin Joison, Speaker at Cardiovascular Conference
Oral Presentation (Virtual)
Agustin Joison, Cordoba Catholic University, Argentina

Introduction: The fibrinolytic activity in human plasma was subsequently shown to depend on activation of a plasminogen as precursor. As plasmin derives from plasminogen, it is possible that microplasmin also has a precursor, microplasminogen. The present study describes the &nbs [....] » Read More

Guo Wei He, Speaker at Cardiovascular Conference
Oral Presentation (Virtual)
Guo Wei He, Tianjin University, China

The LKB1–AMPK signaling pathway is a core regulatory axis of cellular energy homeostasis and a pivotal hub in stress adaptation. As an evolutionarily conserved metabolic sensor, this pathway coordinately regulates glucose, lipid, and protein metabolism, thereby maintaining [....] » Read More

T Rajini Samuel, Speaker at Cardiovascular Diseases Events
Oral Presentation (Virtual)
T Rajini Samuel, Shri Sathya Sai Medical College and Research Institute, India

Introduction: Mobile ECG applications detect the heart's electrical signals from the skin surface using the electrodes and sensors. The signals are amplified and then filtered to remove artifacts. The software identifies the various components of the ECG waves, analyze t [....] » Read More

Geeta Deswal, Speaker at Cardiology Conferences
Oral Presentation (Virtual)
Geeta Deswal, Guru Gobind Singh College of Pharmacy, India

Cardiovascular diseases (CVDs) remain a leading cause of global morbidity and mortality, necessitating the exploration of complementary and integrative therapeutic strategies alongside conventional pharmacotherapy. Herbal medicines and natural products have long been utilized for [....] » Read More

Prashant Sakharam Bhokardankar, Speaker at Cardiovascular Conference
Oral Presentation (Virtual)
Prashant Sakharam Bhokardankar, Datta Meghe Ayurved College, India

The prevalence of cardiovascular diseases (CVDs) has significantly increased in recent years due to environmental changes, heavy diets, and lifestyle modifications. As a result, the term "hridroga," which refers to heart-related conditions in Ayurveda, has grown in popu [....] » Read More

Debprasad Dutta, Speaker at Cardiovascular Diseases Events
Oral Presentation (Virtual)
Debprasad Dutta, Mazumdar Shaw Medical Foundation, India

In vascular medicine, the greatest challenge is not the complexity of the disease, but the silence with which it evolves. We must now harness predictive intelligence to break that silence. This presentation posits that the potential of vascular medicine lies in the seamless in [....] » Read More

Narayanan Gokarneshan, Speaker at Cardiovascular Conference
Oral Presentation (Virtual)
Narayanan Gokarneshan, SSM College of Engineering, India

In cardiovascular therapeutics, procedures such as heart transplants and coronary artery bypass graft are pivotal. However, an acute shortage of organ donors increases waiting times of patients, which is reflected in negative effects on the outcome for the patient. Post-procedura [....] » Read More

Samir Rafla, Speaker at Cardiovascular Diseases Events
Oral Presentation (Virtual)
Samir Rafla, Alexandria University, Egypt

Genetic heart diseases are common causes of sudden cardiac death (SCD) in the young and are typically divided into inherited cardiomyopathies and primary electrical heart diseases. Cardiomyopathies associated with the risk of SCD include hypertrophic cardiomyopathy (HCM) and arrh [....] » Read More

Yasser Mohammed Hassanain Elsayed, Speaker at Heart Conferences
Oral Presentation (Virtual)
Yasser Mohammed Hassanain Elsayed, Egyptian Ministry of Health, Egypt

Rationale: Atrial fibrillation (AF) is the most common arrhythmia. It is known leading cause of ischemic cerebrovascular accidents. Yasser’s fibrillation (sinusoidal AF) or mixed AF is a new cardiovascular discovery. The partial sino-atrial nodal function has an essential r [....] » Read More

Andrey Belousov, Speaker at Cardiovascular Conference
Oral Presentation (Virtual)
Andrey Belousov, Kharkiv National Medical University, Ukraine

A decrease in erythrocyte electrophoretic mobility serves as an important diagnostic marker of pathological conditions associated with impaired gas exchange, microcirculation, and tissue trophism, often leading to systemic hypoxia and deterioration of the patient's clinical s [....] » Read More

Ishan Abdullah, Speaker at Cardiovascular Diseases Events
Poster Presentation (Virtual)
Ishan Abdullah, George Washington University School of Medicine and Health Sciences, United States

Background: Liver cirrhosis is associated with characteristic Electrocardiographic (ECG) and cardiac structural abnormalities, including QTc prolongation and low voltage. In those with heart disease, these changes are often encompassed under the entity of cirrhotic cardiomyopathy [....] » Read More

Heesun Lee, Speaker at Cardiology Conferences
Poster Presentation (Virtual)
Heesun Lee, Seoul National University Hospital, Korea, Republic of

Background: The atherogenic index of plasma (AIP), derived from the triglycerides/high-density lipoprotein cholesterol ratio, reflects the balance between atherogenic and protective lipoproteins. Although it has been associated with cardiovascular risk factors, such as obesity, a [....] » Read More

Steve Cohen, Speaker at Heart Conferences
Keynote Presentation (Virtual)
Steve Cohen, Medvesta Hypnosis Healthcare, United States

This keynote highlights how movement as medicine supports the goals of the Cardiology World Conference 2026 by emphasizing innovative, preventive approaches to heart health. For cardiologists, cardiovascular surgeons, researchers, healthcare practitioners, academicians, industry [....] » Read More

Syed Raza, Speaker at Cardiovascular Conference
Keynote Presentation (Virtual)
Syed Raza, Awali Hospital, Bahrain

Cardiovascular disease (CVD) is the leading cause of death and disability worldwide. The primary prevention of CVD is dependent upon the ability to identify high-risk individuals long before the development of overt events. This highlights the need for accurate risk stratificatio [....] » Read More

Thomas J Webster, Speaker at Heart Conferences
Keynote Presentation (Virtual)
Thomas J Webster, Hebei University of Technology, China

Nanomedicine, or the use of materials with at least one dimension less than 100 nm, has led to improved disease prevention, diagnosis, and treatment. This talk will cover recent advances in the use of nanomaterials to prevent, diagnose, and treat cardiovascular diseases. Specific [....] » Read More

Yayun Du, Speaker at Heart Conferences
Oral Presentation (Virtual)
Yayun Du, Vanderbilt University, United States

Aortic stenosis (AS) is a common and progressive valvular heart disease, particularly in older adults, yet diagnosis and longitudinal monitoring remain highly dependent on access to echocardiography and expert interpretation. Scalable, noninvasive tools that can identify AS and [....] » Read More

Abhinav Grover, Speaker at Cardiovascular Conference
Oral Presentation (Virtual)
Abhinav Grover, University of Pennsylvania, United States

Background: Heart transplantation remains the definitive therapy for end-stage heart failure, but allograft rejection continues to be a major cause of morbidity and graft dysfunction. Traditional surveillance has relied on endomyocardial biopsy (EMB), which provides direct histol [....] » Read More

Trevor Tucker, Speaker at Cardiovascular Diseases Events
Oral Presentation (Virtual)
Trevor Tucker, Dynamic Vascular Resolution Inc., Canada

Introduction: Central artery elasticity is a measure of the artery’s response to the impulse of blood expelled from the left ventricle. The Doppler ultrasound measurement of central artery flow velocity, and its variation over a cardiac cycle, provides a measure of the arte [....] » Read More

Iris Panagiota Efthymiou, Speaker at Cardiovascular Diseases Events
Oral Presentation (Virtual)
Iris Panagiota Efthymiou, Regent College London, United Kingdom

Cardiovascular disease accounts for approximately 18 million deaths annually, yet up to 80% of premature cardiac events are preventable, and medication adherence in chronic cardiovascular conditions remains at just 50–60%. This gap is not a knowledge deficit; it is a behavi [....] » Read More

Franz Porzsolt, Speaker at Heart Conferences
Oral Presentation (Virtual)
Franz Porzsolt, Private Research Institute Clinical Economics, Germany

Background. A team of international cardiologists has suggested replacing the complex experimental “Randomized Controlled Trials (RCTs)” with simpler concepts named “Joint Option”. The idea is perfect, but the solution is rather difficult. Experiments over [....] » Read More

Jeyatheepan Jeyaretnam, Speaker at Cardiovascular Diseases Events
Oral Presentation (Virtual)
Jeyatheepan Jeyaretnam, SPITAL, Switzerland

Cardiovascular disease and tropical infections constitute a major and increasingly interconnected dual burden in underserved regions, particularly within low- and middle-income countries where healthcare systems remain fragmented and resource-constrained. This poster proposes a s [....] » Read More

Jeyatheepan Jeyaretnam, Speaker at Cardiovascular Diseases Events
Oral Presentation (Virtual)
Jeyatheepan Jeyaretnam, SPITAL, Switzerland

Introduction: Modern cardiovascular care is rapidly evolving toward integrated, multidisciplinary management supported by advanced diagnostic and monitoring technologies. The “Heart Team” model, endorsed by the European Society of Cardiology, promotes collaborati [....] » Read More

Joao Rafael De Oliveira Rocha Da Silva, Speaker at Heart Conferences
Oral Presentation (Virtual)
Joao Rafael De Oliveira Rocha Da Silva, Connect Life Rehabilitation and Performance, Brazil

Chronic pain is associated with the leading cause of disability in the world, just as cardiovascular diseases represent the highest incidence of death in the world. Both pathologies generate a high demand for health services and represent a high global population risk. In [....] » Read More

N K Shelukhanov, Speaker at Heart Conferences
Oral Presentation (Virtual)
N K Shelukhanov, Almazov National Medical Research Center, Russian Federation

Relevance: Obesity is a leading modifiable risk factor for cardiovascular diseases (CVD). Despite the recognized role of physical activity (PA) in the treatment of obesity, existing recommendations are general in nature, which reduces their effectiveness and safety. Determin [....] » Read More

Muhammet Vasfi Gokay, Speaker at Heart Conferences
Oral Presentation (Virtual)
Muhammet Vasfi Gokay, Sultan Abdülhamid Han Training and Research Hospital, Turkey

Introduction: Quadricuspid aortic valve (QAV) is an exceedingly rare congenital cardiac malformation, with an estimated incidence of 0.008% to 0.043%. It is primarily characterized by the presence of four functional cusps, which often leads to progressive aortic regurgitation (AR [....] » Read More

Krishna Priya Jha, Speaker at Cardiovascular Diseases Events
Oral Presentation (Virtual)
Krishna Priya Jha, NIPER, India

Herbs have long served as foundational sources of medicinal agents and continue to play a pivotal role in both traditional and modern pharmaceutical practices. Among these, several naturally derived compounds exhibit promising therapeutic potential against cardiovascular diseases [....] » Read More

A Jamuna Rani, Speaker at Heart Conferences
Oral Presentation (Virtual)
A Jamuna Rani, Sree Balaji Medical College and Hospital, India

Will be Updated Soon...

Reshma Gopan, Speaker at Cardiovascular Diseases Events
Oral Presentation (Virtual)
Reshma Gopan, PMS College of Dental Science and Research, India

Introduction: A concerning increase in coronary artery disease (CAD) among younger Indians calls attention to genetic biomarkers that indicate early vascular stress. The tumor suppressor gene p53, known primarily for its oncogenic role, also modulates vascular apoptosis and infla [....] » Read More

Nilay Solanki, Speaker at Heart Conferences
Oral Presentation (Virtual)
Nilay Solanki, Charotar University of Science and Technology, India

Background: Cardiovascular diseases (CVDs) are major health problem throughout the world and common cause of premature morbidity and mortality. Today CVD accounts for approximately 30% deaths worldwide including nearly 40% in high income countries and about 28% in middle and low [....] » Read More

Abhishek Bansal, Speaker at Cardiovascular Conference
Oral Presentation (Virtual)
Abhishek Bansal, New Era Consultancy Services, India

Contemporary cardiac disease modeling and electrocardiographic interpretation remain largely dominated by waveform-centric heuristics, statistical signal processing, and black-box artificial intelligence. Although such methods may provide empirical classification, they often fail [....] » Read More

Maryam Mobasheri Shiri, Speaker at Cardiovascular Conference
Oral Presentation (Virtual)
Maryam Mobasheri Shiri, Fasa University of Medical Science, Iran (Islamic Republic of)

Statement of the Problem: Air pollutants can affect the human cardiovascular system, but their impact on cardiac conduction remains unclear. We have undertaken a systematic review to compile the existing evidence Methodology & Theoretical Orientation: We conducted a compre [....] » Read More

Watsapp